Patents by Inventor Manjunatha Ujjini

Manjunatha Ujjini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS
    Publication number: 20190030009
    Abstract: The invention relates to a method for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of cryptosporidiosis by administering a therapeutic agent which antagonizes or modulates the activity of phosphatidylinositol-4-OH kinase (PI4K), a lipid kinase of the cryptosporidium protozoa. In one embodiment, the therapeutic agent is a pyrazolo[1,5-a]pyridine compound of Formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein.
    Type: Application
    Filed: January 20, 2017
    Publication date: January 31, 2019
    Inventors: Thierry Tidiane DIAGANA, Manjunatha UJJINI
  • Pyridone derivatives and uses thereof in the treatment of tuberculosis
    Patent number: 9546138
    Abstract: A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the inhibition of mycolic acid biosynthesis through inhibition of M. tuberculosis Enoyl Acyl Carrier Protein Reductase enzyme (InhA): wherein R1, R2, R3, R4 and R5 are as defined herein.
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: January 17, 2017
    Assignee: Novartis AG
    Inventors: Ravinder Reddy Kondreddi, Ngai Ling Ma, Stefan Peukert, Srinivasa P S Rao, Manjunatha Ujjini